Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2750
Single User License Price INR 196323
Corporate User License Price USD 4500
Corporate User License Price INR 321255
Site License Price USD 3500
Site License Price INR 249865
Request a Quote

Report Title

Global Brachytherapy Therapy Market 2018-2024

Quote Request for License Type
License Type Price  
Single User License USD 2750
Site License USD 3500
Enterprise Wide License USD 4500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Global Brachytherapy Therapy Market 2018-2024


Quote Request for License Type
License Type Price  
Single User License USD 2750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Global Brachytherapy Therapy Market 2018-2024

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Global Brachytherapy Therapy Market 2018-2024



Executive Summary

Global Brachytherapy Devices Market-Drivers, Opportunities, Trends, and Forecasts: 2018-2024

Overview:

Brachytherapy is a medical procedure popularly referred to as radiation therapy. It is used to treat various types of cancers which involves placing radioactive materials inside the body, which is called internal radiation. Surgeons deliver high dose of radiation to the target site. There are fewer side effects and complications involved in this procedure than surgery and external beam radiation. Brachytherapy is administered with high precision, in high doses, and is localized. Brachytherapy procedure is as follows:

A thin catheter is placed at the target site or in the tumor and is connected to a high-dose rate (HDR) afterload. The system consists of a single highly radioactive indium pellet at the tip of the wire. The pellet is pushed into the catheter one by one (performed under computer control). This is called dwell time. The pellet is stopped near the target site to release radiation at the dwell position. Brachytherapy offers precise treatment for few minutes and after a series of treatment, the catheters are removed from the target site and the individual may finally have no radioactive seeds left inside the body.

Brachytherapy is considered the best way of eliminating or destroying cancerous tissues. This treatment has the potential to kill cancer cells and shrink tumors. It involves no external X-ray beams and surgery and has minimal invasiveness. Internal beam radiation therapy allows a higher dose of radiation in a smaller target area. This may not be possible with external beam radiation therapy. It uses a radiation dose source that is usually sealed in a small holder known as an implant. Brachytherapy helps to identify and position the device appropriately to aim at the target site providing an effective treatment for tumor. It takes lesser time than other procedures. The special preparations required before initiating Brachytherapy are: Bowel preparation, blood test, pre-treatment (ultrasound, CT or MRI scan)

The Brachytherapy device market is progressing at a steady pace and is expected to grow at a rapid rate in the emerging economies. According to the estimation of the National Cancer Institute, in the US around 1.6 million new cases of cancer were diagnosed, and 595,690 people died due to cancer in 2016. Cancer is one of the biggest causes of mortality and morbidity in Europe after cardiovascular diseases. The highest cancer rate for men and women together was found in Denmark with 338 people per 100,000, the highest for any EU country. According to ICMR, India is likely to have over 17.3 lakh new cases of cancer and over 8.8 lakh deaths due to the disease by 2020 with breast, lung, and cervical cancers topping the list.

The main products in the Brachytherapy market include:

Oncentra Brachy Treatment Planning System by Elekta

Brachytherapy Afterloaders and Applicators by Varian Medical Systems

SOURCELINK Delivery System by C.R. Bard (now BD)

FASTFILL Brachytherapy Needle by C.R. Bard (now BD)

IsoSeed, IsoStrand, and LDR Needles by Eckert & Ziegler BEBIG

TheraStrand-Strand and AnchorLoad-needle by Theragenics

Market Analysis:

The Global Brachytherapy Device Market is estimated to witness a CAGR of 6.06% during the forecast period 2018-2024. The market is analyzed based on three segments, namely product type, end-users, and regions.

Regional Analysis:

The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is set to be the leading region for the brachytherapy devices growth followed by the Europe. Asia Pacific and ROW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in the patient population and their focus toward healthcare infrastructure. The brachytherapy devices market has the lowest penetration in the emerging market and most of the vendors are targeting to penetrate countries such as India, China, Thailand, and Vietnam.

APAC is the most focused and has substantial growth due to vast opportunities for vendors to establish their presence. Factors such as growing public awareness, increase in aging population, growing assisted living facilities, presence of large potential customer base, and increased initiatives by government support will boost the market growth. The region is witnessing a rapid growth in the healthcare industry as well. The emerging countries such as India and China are majorly focusing to improve their healthcare infrastructure and the governments have taken initiatives to develop the healthcare facilities in both urban and rural areas. The increased demand for better services among patients and the increased life expectancy in this region are factors that will boost the overall healthcare facility in the region. Also, countries in this region have a strong focus towards the development of healthcare that will include coverage for patients aged 65 and above.

Product Analysis:

Brachytherapy devices market is expected to increase rapidly. HDR segment has the maximum share in the global brachytherapy devices market. Developments in imaging technology coupled with advancements in computer technology, have revolutionized the processes for tumor targeting and radiation therapy planning. Technologies used in internal beam radiation therapy include high dose rate (HDR) brachytherapy, low dose rate (LDR) brachytherapy, intermediate dose rate, and pulsed dose rate; and products include seeds, applicators, after loaders, and accessories. Based on applications, the market is segmented into prostate cancer, cervical cancer, gallbladder, uterus, breast cancer, lung cancer, head & neck cancer, brain cancer, and others. Based on end-users, the market is segmented into hospitals, radiation therapy centers, ambulatory service centers, and others.

Key Players:

Elekta AB, Varian Medical Systems, C.R. Bard (now Becton, Dickinson and Company), Eckert & Ziegler BEBIG SA, and Theragenics are the predominant players in the current brachytherapy devices market.

Competitive Analysis:

The global brachytherapy devices market is highly fragmented and has immense growth opportunities for vendors, especially in the developing regions. The market enjoys the participation of many global, regional, and local players who are competing fiercely to gain a strong foothold as top vendor. Big players, such Elekta AB, Varian Medical Systems, and C.R. Bard (now BD) often acquire small yet promising companies to increase their market share. Most giant companies are using acquisition strategies to expand their business operations by leveraging their products portfolio across the globe. The competitive environment in the market will intensify further with an increase in product/service extensions, product innovations, and M&A. Strategic alliances are being formed to manufacture and market brachytherapy devices more vigorously and efficiently

Benefits:

The report provides complete details about the usage and adoption rate of brachytherapy devices for the treatment of various cancer. Thus, the key stakeholders can find out all the relevant details about the latest trends, drivers, investments, vertical players' initiatives, and government initiatives toward the radiation industry in the upcoming years. The report also provides details of the pure play companies entering the market. Moreover, the report highlights the major challenges that are going to impact the market growth. Additionally, it brings forth the key business opportunities to prominent stakeholders to aid them in expanding their businesses and capture the revenue in specific verticals. It also aims to help stakeholders analyze the pros and cons of this market before investing or expanding the business in this arena.

Key Stakeholders:

 

Table of Contents

1 Industry Outlook 10

1.1 Industry Overview 10

1.2 Patient demographics 12

1.3 Healthcare Spending in the US 14

1.4 Definition: Brachytherapy 15

1.5 Why brachytherapy? 15

1.6 Industry Trends 15

1.7 Emerging Global Markets 16

2 Report Outline 18

2.1 Report Scope 18

2.2 Report Summary 18

2.3 Research Methodology 19

2.4 Report Assumptions 20

3 Market Snapshot 21

3.1 Total Addressable Market (TAM) 21

3.2 Funding Scenario 22

3.3 Segmented Addressable Market (SAM) 22

3.4 Porter 5 (Five) Forces 25

3.5 Market Dynamics 26

3.5.1 Drivers 27

3.5.1.1 Rise in the incidence of cancer globally 27

3.5.1.2 Increasing popularity of MI surgeries 27

3.5.1.3 Increase in the number of outpatient procedures 27

3.5.1.4 Rise in elderly population 28

3.5.2 Restraints 28

3.5.2.1 Complications and risks associated with brachytherapy procedures 28

3.5.2.2 High costs of instrument and therapy 28

3.5.2.3 Lack of trained technicians in developing countries 29

3.5.2.1 Intense competition among vendors 29

3.5.3 Opportunities 29

3.5.3.1 Advancement in technology 29

3.5.3.2 Increasing adoption of non-invasive procedures in emerging countries 30

3.5.3.1 Increasing healthcare spending 30

3.5.3.1 Shift toward minimal and non-invasive procedures 31

3.5.4 DRO-Impact Analysis 32

3.5.5 Key Stakeholders 33

4 Brachytherapy Market Segmentation by Methods: Market Size & Analysis 34

4.1 Overview 34

4.2 High-dose Rate Brachytherapy Market 37

4.2.1 Overview 37

4.3 Low-dose Rate Brachytherapy Market 37

4.3.1 Overview 37

4.4 Intermediate Dose Rate Brachytherapy Market 38

4.4.1 Overview 38

4.5 Pulsed Dose Rate Brachytherapy Market 39

4.5.1 Overview 39

5 Brachytherapy Market Segmentation By consumables 40

5.1 Overview 40

5.2 Seeds 40

5.3 Applicators, Afterloaders, and Other Accessories 41

6 Brachytherapy Market Segmentation by Applications 43

6.1 Overview 43

6.2 Prostate Cancer 43

6.3 Cervical Cancer 44

6.4 Breast Cancer 44

6.5 Lung Cancer 45

6.6 Head & Neck Cancer 46

6.7 Brain Cancer 47

6.8 Others 47

7 End-users: Market Size and Analysis 48

7.1 Overview 48

7.2 Hospitals 48

7.3 Radiation Therapy Centers 49

7.4 Ambulatory Surgery Centers 49

7.5 Others 49

8 Regions: Market Size & Analysis 51

8.1 Overview 51

8.2 North America 52

8.2.1 Market Overview 52

8.2.2 US 53

8.2.3 Canada 54

8.3 Europe 54

8.3.1 Market Overview 54

8.3.2 UK 55

8.3.3 Germany 55

8.3.4 France 56

8.3.5 Spain 56

8.4 APAC 56

8.4.1 Market Overview 56

8.4.2 India 57

8.4.3 China 58

8.4.4 Japan 59

8.5 Rest of the World 59

8.5.1 Market Overview 59

8.5.2 Brazil 60

8.5.3 Middle East 60

9 Competitive Landscape 62

9.1 Competitor Comparison Analysis 62

10 Vendor Profiles 64

10.1 Elekta AB 64

10.1.1 Overview 64

10.1.2 Geographic Revenue 68

10.1.3 Business Focus 68

10.1.4 SWOT Analysis 69

10.1.5 Business Strategies 69

10.2 Varian Medical Systems Inc. 70

10.2.1 Overview 70

10.2.2 Business Units 74

10.2.3 Geographic Revenue 75

10.2.4 Business Focus 75

10.2.5 SWOT Analysis 76

10.2.6 Business Strategies 76

10.3 C. R. Bard Inc. 78

10.3.1 Overview 78

10.3.2 Business Units 80

10.3.3 Business Focus 81

10.3.4 SWOT Analysis 81

10.3.5 Business Strategies 81

10.4 Eckert & Ziegler BEBIG 83

10.4.1.1 Overview 83

10.4.1.2 Business Units 85

10.4.1.3 Business Units 85

10.4.1.4 Geography 86

10.4.1.5 Business Focus 86

10.4.1.6 SWOT Analysis 87

10.4.1.7 Business Strategies 87

10.5 Theragenics Corp 88

10.5.1.1 Overview 88

10.5.1.2 Business Units 89

10.5.1.3 Business Focus 89

10.5.1.4 SWOT Analysis 89

10.5.1.5 Business Strategies 90

11 Companies to watch for 90

11.1 Carl Zeiss Meditec AG 91

11.1.1 Overview 91

11.2 Mevion Medical Systems Inc. 92

11.2.1 Overview 92

11.3 Nordion Inc. 93

11.3.1 Overview 93

11.4 IsoRay Inc. 95

11.4.1 Overview 95

11.5 Hitachi Medical Corp. 96

11.5.1 Overview 96

11.6 ViewRay Inc. 98

11.6.1 Overview 98

 

 

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Charts

 

CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 11

CHART 2 AGEING DEMOGRAPHIC GROWTH 13

CHART 3 US POPULATION DISTRIBUTION BY AGE (US, CENSUS BUREAU, CMS 2015) 13

CHART 4 US HEALTHCARE CONSUMPTION BY AGE (US, CENSUS BUREAU, CMS 2015) 14

CHART 5 WORLD POPULATION AGED 65 YEARS AND ABOVE, 1960-2060 (%) 14

CHART 6 GLOBAL HEALTHCARE EXPENDITURE GDP AND PER-CAPITA SPENDING IN 2015 16

CHART 8 RESEARCH METHODOLOGY 19

CHART 9 GLOBAL RADIATION ONCOLOGY MARKET BY THERAPY TYPE, 2017 (%) 22

CHART 10 GLOBAL BRACHYTHERAPY DEVICES MARKET REVENUE, 2017-2024 (USD MILLION) 23

CHART 11 PORTERS 5 FORCES ON BRACHYTHERAPY DEVICES MARKET 25

CHART 12 MARKET DYNAMICS-DRIVERS, RESTRAINTS & OPPORTUNITIES 26

CHART 13 DRO-IMPACT ANALYSIS OF BRACHYTHERAPY DEVICES MARKET 32

CHART 14 KEY STAKEHOLDERS 33

CHART 15 GLOBAL BRACHYTHERAPY DEVICES MARKET BY TYPE SEGMENTATION, 2017 (% SHARE) 34

CHART 16 GLOBAL BRACHYTHERAPY DEVICES MARKET BY TYPE SEGMENTATION, 2024 (% SHARE) 35

CHART 17 GLOBAL BRACHYTHERAPY DEVICES MARKET OVERVIEW BY PRODUCT TYPE 2017 35

CHART 18 GLOBAL HIGH-DOSE RATE BRACHYTHERAPY MARKET BY REVENUE, 2017-2024 (USD MILLION) 37

CHART 19 GLOBAL LOW DOSE RATE BRACHYTHERAPY MARKET BY REVENUE, 2017-2024 (USD MILLION) 38

CHART 20 GLOBAL INTERMEDIATE DOSE RATE MARKET BY REVENUE, 2017-2024 (USD MILLION) 38

CHART 21 GLOBAL PULSED DOSE RATE MARKET BY REVENUE, 2017-2024 (USD MILLION) 39

CHART 22 GLOBAL BRACHYTHERAPY DEVICES MARKET SHARE BY CONSUMABLES SEGMENTATION, 2017 (%) 40

CHART 23 GLOBAL BRACHYTHERAPY DEVICES MARKET SEGMENTATION BY PRODUCT TYPE, 2017-2024 (USD MILLION) 41

CHART 24 GLOBAL BRACHYTHERAPY DEVICES MARKET SEGMENTATION BY PRODUCT TYPE, 2016-2023 (% SHARE) 42

CHART 25 GLOBAL BRACHYTHERAPY MARKET SHARE BY APPLICATION SEGMENTATION, 2017 (%) 43

CHART 26 GLOBAL BRACHYTHERAPY MARKET SHARE BY END-USERS SEGMENTATION, 2017 (%) 48

CHART 27 GLOBAL BRACHYTHERAPY DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 51

CHART 28 GLOBAL BRACHYTHERAPY DEVICES MARKET OVERVIEW BY REGIONS 2017 (USD MILLION) 51

CHART 29 BRACHYTHERAPY DEVICES MARKET REVENUE IN NORTH AMERICA, 2017-2024 (USD MILLION) 52

CHART 30 BRACHYTHERAPY DEVICES MARKET REVENUE IN THE EUROPE, 2017-2024 (USD MILLION) 54

CHART 31 BRACHYTHERAPY DEVICES MARKET REVENUE IN THE APAC, 2017-2024 (USD MILLION) 57

CHART 32 BRACHYTHERAPY DEVICES MARKET REVENUE IN THE REST OF THE WORLD, 2017-2024 (USD MILLION) 59

CHART 33 GLOBAL BRACHYTHERAPY DEVICES MARKET SEGMENTATION BY GEOGRAPHY, 2017-2024 (USD MILLION) 60

CHART 34 GLOBAL BRACHYTHERAPY DEVICES MARKET SEGMENTATION BY GEOGRAPHY, 2017-2024 (%) 61

CHART 35 ELEKTA AB: OVERVIEW SNAPSHOT 65

CHART 36 ELEKTA AB: GEOGRAPHIC REVENUE 68

CHART 37 ELEKTA AB: SWOT ANALYSIS 69

CHART 38 VARIAN MEDICAL SYSTEMS INC.: OVERVIEW SNAPSHOT 72

CHART 39 VARIAN MEDICAL SYSTEMS INC.: BUSINESS UNITS 74

CHART 40 VARIAN MEDICAL SYSTEMS INC.: GEOGRAPHIC REVENUE 75

CHART 41 VARIAN MEDICAL SYSTEMS INC.: SWOT ANALYSIS 76

CHART 42 C. R. BARD INC.: OVERVIEW SNAPSHOT 79

CHART 43 C. R. BARD INC.: BUSINESS UNITS 80

CHART 44 C. R. BARD INC.: SWOT ANALYSIS 81

CHART 45 ECKERT & ZIEGLER BEBIG: OVERVIEW SNAPSHOT 84

CHART 46 ECKERT & ZIEGLER BEBIG: BUSINESS UNITS 86

CHART 47 ECKERT & ZIEGLER BEBIG: GEOPGRAPHICAL PRESENCE 86

CHART 48 ECKERT & ZIEGLER BEBIG: SWOT ANALYSIS 87

CHART 49 THERAGENICS CORP: SWOT ANALYSIS 89

 

Tables

 

TABLE 1 FUNDING SCENARIO 22

TABLE 2 GLOBAL BRACHYTHERAPY DEVICES MARKET BY TYPES, 2017-2024 (USD MILLION) 36

TABLE 3 GLOBAL BRACHYTHERAPY DEVICES MARKET REVENUE BY REGIONS FORECAST, 2017-2024 (USD MILLION) 52

TABLE 1 GLOBAL BRACHYTHERAPY DEVICES MARKET BY VENDOR RANKING, 2017 63

TABLE 2 ELEKTA AB: PRODUCT OFFERINGS 64

TABLE 3 ELEKTA AB: RECENT DEVELOPMENTS 66

TABLE 4 VARIAN MEDICAL SYSTEMS INC.: PRODUCT OFFERINGS 70

TABLE 5 VARIAN MEDICAL SYSTEMS INC.: RECENT DEVELOPMENTS 72

TABLE 6 C. R. BARD INC.: PRODUCT OFFERINGS 78

TABLE 7 C. R. BARD INC.: RECENT DEVELOPMENTS 79

TABLE 8 ECKERT & ZIEGLER BEBIG: PRODUCT OFFERINGS 83

TABLE 9 ECKERT & ZIEGLER BEBIG: RECENT DEVELOPMENTS 83

TABLE 10 THERAGENICS CORP: PRODUCT OFFERINGS 88

TABLE 11 THERAGENICS CORP: RECENT DEVELOPMENTS 88

TABLE 12 CARL ZEISS MEDITEC AG: SNAPSHOT 91

TABLE 13 CARL ZEISS MEDITEC AG: RECENT DEVELOPMENTS 91

TABLE 14 MEVION MEDICAL SYSTEMS INC.: SNAPSHOT 92

TABLE 15 MEVION MEDICAL SYSTEMS INC.: RECENT DEVELOPMENTS 92

TABLE 16 NORDION INC.: SNAPSHOT 93

TABLE 17 NORDION INC.: RECENT DEVELOPMENTS 93

TABLE 18 ISORAY INC.: SNAPSHOT 95

TABLE 19 ISORAY INC.: RECENT DEVELOPMENTS 95

TABLE 20 HITACHI MEDICAL CORP.: SNAPSHOT 96

TABLE 21 HITACHI MEDICAL CORP.: RECENT DEVELOPMENTS 96

TABLE 22 VIEWRAY INC.: SNAPSHOT 98

TABLE 23 VIEWRAY INC.: RECENT DEVELOPMENTS 98

 

Elekta AB, Varian Medical Systems, C.R. Bard (now Becton, Dickinson and Company), Eckert & Ziegler BEBIG SA, and Theragenics are the predominant players in the current brachytherapy devices market


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person